Oxidative stress contributes to muscular fatigue. GSH is the major intracel
lular antioxidant, the biosynthesis of which is dependent on cysteine avail
ability. We hypothesized that supplementation with a whey-based cysteine do
nor [Immunocal (HMS90)] designed to augment intracellular GSH would enhance
performance. Twenty healthy young adults (10 men, 10 women) were studied p
resupplementation and 3 mo postsupplementation with either Immunocal (20 g/
day) or casein placebo. Muscular performance was assessed by whole leg isok
inetic cycle testing, measuring peak power and 30-s work capacity. Lymphocy
te GSH was used as a marker of tissue GSH. There were no baseline differenc
es (age, ht, wt, %ideal wt, peak power, 30-s work capacity). Follow-up data
on 18 subjects (9 Immunocal, 9 placebo) were analyzed. Both peak power [13
+/- 3.5 (SE) %, P < 0.02] and 30-s work capacity (13 +/- 3.7%, P < 0.03) i
ncreased significantly in the Immunocal group, with no change (2 +/- 9.0 an
d 1 +/- 9.3%) in the placebo group. Lymphocyte GSH also increased significa
ntly in the Immunocal group (35.5 +/- 11.04%, P < 0.02), with no change in
the placebo group (-0.9 +/- 9.6%). This is the first study to demonstrate t
hat prolonged supplementation with a product designed to augment antioxidan
t defenses resulted in improved volitional performance.